Listen to Elizabeth R. Plimack, MD, MS; Brian A. Costello, MD; and Martin H. Voss, MD, discuss current best practices for first-line immunotherapy treatment of advanced renal cell carcinoma.
In this episode, Elizabeth R. Plimack, MD, MS; Brian A. Costello, MD; and Martin H. Voss, MD, discuss current best practices for the first-line treatment of patients with metastatic renal cell carcinoma (RCC). Topics include:
Presenters: Elizabeth R. Plimack, MD, MS Brian A. Costello, MD Martin H. Voss, MD Content based on an online CME program supported by educational grants from Eisai, Exelixis, Pfizer and EMD Serono, and Merck Sharp & Dohme Corp. Link to full program: https://bit.ly/32IS9gx |